Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MHPG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 99 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yamauchi, K; Yamada, S; Morita, K; Maeda, H; Tanaka, M
      Comparative study of short-term anxiolytic potency of alprazolam and tandospirone in psychiatric outpatients with anxiety disorders

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    2. Nakamura, J; Yoshimura, R; Okuna, T; Ueda, N; Hachida, M; Yasumoto, K; Egami, H; Maeda, H; Nishi, M; Aoyagi, S
      Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    3. Yajima, J; Tsuda, A; Yamada, S; Tanaka, M
      Determination of saliva free-3-methoxy-4-hydroxyphenylglycol in normal volunteers using gas chromatography mass spectrometry

      BIOGENIC AMINES
    4. Hedou, G; Pryce, C; Di Iorio, L; Heidbreder, CA; Feldon, J
      An automated analysis of rat behavior in the forced swim test

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    5. Raggi, MA; Sabbioni, C; Pucci, V; Ghedini, N; Calonghi, N; Gerra, G
      Sensitive determination of 3-methoxy-4-hydroxyphenylglycol (MHPG) in humanplasma hy HPLC with electrochemical detection

      CHROMATOGRAPHIA
    6. Leonard, BE
      Noradrenaline and depression

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    7. Backman, J; Alling, C; Alsen, M; Regnell, G; Traskman-Bendz, L
      Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Tripodianakis, J; Markianos, M; Sarantidis, D; Leotsakou, C
      Neurochemical variables in subjects with adjustment disorder after suicideattempts

      EUROPEAN PSYCHIATRY
    9. Yoshimura, R; Yamada, Y; Ueda, N; Nakamura, J
      Changes in plasma monoamine metabolites during acute lithium intoxication

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    10. Patat, A; Rosenzweig, P; Enslen, M; Trocherie, S; Miget, N; Bozon, MC; Allain, H; Gandon, JM
      Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    11. Yamada, S; Yamauchi, K; Yajima, J; Hisadomi, S; Maeda, H; Toyomasu, K; Tanaka, M
      Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders

      PSYCHIATRY RESEARCH
    12. Delgado, PL
      Depression: The case for a monoamine deficiency

      JOURNAL OF CLINICAL PSYCHIATRY
    13. Jonsson, EG; Norton, N; Gustavsson, JF; Oreland, L; Owen, MJ; Sedvall, GC
      A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers

      JOURNAL OF PSYCHIATRIC RESEARCH
    14. Farren, CK; Tipton, KF
      The urinary MHPG/creatinine ratio and its relationship to platelet monoamine oxidase activity in abstinent alcoholics

      ADDICTION BIOLOGY
    15. Krahn, LE; Lin, SC; Klee, GG; Lu, PY; Ory, SJ; Zimmermann, RC
      The effect of presynaptic catecholamine depletion on 6-hydroxymelatonin sulfate: a double blind study of alpha-methyl-para-tyrosine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Kaye, WH; Frank, GKW; McConaha, C
      Altered dopamine activity after recovery from restricting-type anorexia nervosa

      NEUROPSYCHOPHARMACOLOGY
    17. Swann, AC; Petty, F; Bowden, CL; Dilsaver, SC; Calabrese, JR; Morris, DD
      Mania: gender, transmitter function, and response to treatment

      PSYCHIATRY RESEARCH
    18. Shiah, IS; Ko, HC; Lee, JF; Lu, RB
      Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls

      JOURNAL OF AFFECTIVE DISORDERS
    19. Lappalainen, J; Long, JC; Virkkunen, M; Ozaki, N; Goldman, D; Linnoila, M
      HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses

      BIOLOGICAL PSYCHIATRY
    20. Clarke, AS; Ebert, MH; Schmidt, DE; McKinney, WT; Kraemer, GW
      Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys

      BIOLOGICAL PSYCHIATRY
    21. INAGAKI H; HIRATA K; MINAMI M
      SEPARATE DETERMINATION OF HUMAN URINARY CONJUGATED AND UNCONJUGATED 3-METHOXY-4-HYDROXYPHENYLETHYLENEGLYCOL

      Journal of chromatography B. Biomedical sciences and applications
    22. YAMADA S; YAJIMA J; HARANO M; MIKI K; NAKAMURA J; TSUDA A; SHOJI H; MAEDA H; TANAKA M
      SALIVA LEVEL OF FREE 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN PSYCHIATRIC OUTPATIENTS WITH ANXIETY

      International clinical psychopharmacology
    23. BENASSINI O; CAMARENA B; CRUZ B; CRUZ C; DELAFUENTE JR; GUAJARDO R; HEINZE G; HERRERA K; DOLENGEVICH H; MADRIGAL A; PAEZ F; NICOLINI H
      CLINICAL-VARIABLES, MOLECULAR GENOTYPES AND PERSONALITY AS PREDICTORSANTIDEPRESSANT RESPONSE - A PARALLEL STUDY OF A CLINICAL-TRIAL OF FLUVOXAMINE VS. IMIPRAMINE

      Salud mental
    24. STUERENBURG HJ; KUNZE K
      INTRAVENOUS THERAPY WITH NOREPINEPHRINE LEADS TO EXCESSIVELY ELEVATEDCONCENTRATIONS OF 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN CSF IN PATIENTS WITH SUBARACHNOID HEMORRHAGE

      Biogenic amines
    25. JONSSON EG; NOTHEN MM; GUSTAVSSON JP; NEIDT H; BUNZEL R; PROPPING P; SEDVALL GC
      POLYMORPHISMS IN THE DOPAMINE, SEROTONIN, AND NOREPINEPHRINE TRANSPORTER GENES AND THEIR RELATIONSHIPS TO MONOAMINE METABOLITE CONCENTRATIONS IN CSF OF HEALTHY-VOLUNTEERS

      Psychiatry research
    26. MAZURE CM; BOWERS MB
      PRETREATMENT PLASMA HVA PREDICTS NEUROLEPTIC RESPONSE IN MANIC PSYCHOSIS

      Journal of affective disorders
    27. HOLLENBACH E; SCHULZ C; LEHNERT H
      RAPID AND SENSITIVE DETERMINATION OF CATECHOLAMINES AND THE METABOLITE 3-METHOXY-4-HYDROXYPHEN-ETHYLENEGLYCOL USING HPLC FOLLOWING NOVEL EXTRACTION PROCEDURES

      Life sciences (1973)
    28. WANG P; KITAYAMA I; NOMURA J
      TYROSINE-HYDROXYLASE GENE-EXPRESSION IN THE LOCUS-COERULEUS OF DEPRESSION-MODEL RATS AND RATS EXPOSED TO SHORT-TERM AND LONG-TERM FORCED WALKING STRESS

      Life sciences
    29. GURGUIS GNM; UHDE TW
      THE RELATIONSHIP BETWEEN PLASMA MHPG AND NE - EMPLOYING REGRESSION-MODELS IN ESTIMATING CENTRALLY DERIVED MHPG AND PERIPHERAL NE TURNOVER RATE IN PANIC DISORDER

      Journal of Psychiatric Research
    30. MOCHIZUKI Y; OISHI M; TAKASU T
      CORRELATIONS BETWEEN P300 COMPONENTS AND NEUROTRANSMITTERS IN THE CEREBROSPINAL-FLUID

      Clinical EEG electroencephalography
    31. YAMASHITA K; KITAYAMA I; HAMANAKA K; NOMURA J
      EFFECT OF RESERPINE ON 3-METHOXY-4-HYDROXYPHENYLETHYLENEGLYCOL AND 3,4-DIHYDROXYPHENYLACETIC ACID IN THE HIPPOCAMPUS OF DEPRESSION-MODEL RATS - AN IN-VIVO MICRODIALYSIS STUDY

      Brain research
    32. GURGUIS GNM; YONKERS KA; PHAN SP; BLAKELEY JE; WILLIAMS A; RUSH AJ
      ADRENERGIC-RECEPTORS IN PREMENSTRUAL DYSPHORIC DISORDER - I - PLATELET ALPHA(2) RECEPTORS - G(I) PROTEIN COUPLING, PHASE OF MENSTRUAL-CYCLE, AND PREDICTION OF LUTEAL-PHASE SYMPTOM SEVERITY

      Biological psychiatry
    33. MONTGOMERY SA
      IS THERE A ROLE FOR A PURE NORADRENERGIC DRUG IN THE TREATMENT OF DEPRESSION

      European neuropsychopharmacology
    34. HALPERIN JM; NEWCORN JH; KODA VH; PICK L; MCKAY KE; KNOTT P
      NORADRENERGIC MECHANISMS IN ADHD CHILDREN WITH AND WITHOUT READING DISABILITIES - A REPLICATION AND EXTENSION

      Journal of the American Academy of Child and Adolescent Psychiatry
    35. NAKAMURA J; UCHIMURA N; YAMADA S; MAEDA H; ISHIDA S; TSUCHIYA S; HIRANO T; ISHII H; TAKAYAMA K; KOTORII T
      MIANSERIN SUPPOSITORIES IN THE TREATMENT OF POSTOPERATIVE DELIRIUM

      Human psychopharmacology
    36. REDMOND AM; LEONARD BE
      AN EVALUATION OF THE ROLE OF THE NORADRENERGIC SYSTEM IN THE NEUROBIOLOGY OF DEPRESSION - A REVIEW

      Human psychopharmacology
    37. PERRY KW; FULLER RW
      FLUOXETINE INCREASES NOREPINEPHRINE RELEASE IN RAT HYPOTHALAMUS AS MEASURED BY TISSUE-LEVELS OF MHPG-SO4 AND MICRODIALYSIS IN CONSCIOUS RATS

      Journal of neural transmission
    38. YAO JK; ZHU P; WILDS DJ; VANKAMMEN DP
      A SIMPLIFIED ROUTINE ASSAY FOR URINARY 3-METHOXY-4-HYDROXYPHENYLGLYCOL

      Journal of neural transmission
    39. NAKAMURA J; UCHIMURA N; YAMADA S; NAKAZAWA Y
      DOES PLASMA-FREE 3-METHOXY-4-HYDROXYPHENYL(ETHYLENE)GLYCOL INCREASE IN THE DELIRIOUS STATE - A COMPARISON OF THE EFFECTS OF MIANSERIN AND HALOPERIDOL ON DELIRIUM

      International clinical psychopharmacology
    40. OTTONG SE; GARVER DL
      A BIOMODAL DISTRIBUTION OF PLASMA HVA MHPG IN THE PSYCHOSES/

      Psychiatry research
    41. GRAYSON RH; HALPERIN JM; SHARMA V; SCHWARTZ ST; KODA VH; NEWCORN JH
      CHANGES IN PLASMA PROLACTIN AND CATECHOLAMINE METABOLITE LEVELS FOLLOWING ACUTE NEEDLE STICK IN CHILDREN

      Psychiatry research
    42. TORDJMAN S; ANDERSON GM; MCBRIDE PA; HERTZIG ME; SNOW ME; HALL LM; THOMPSON SM; FERRARI P; COHEN DJ
      PLASMA BETA-ENDORPHIN, ADRENOCORTICOTROPIN HORMONE, AND CORTISOL IN AUTISM

      Journal of child psychology and psychiatry and allied disciplines
    43. CURTIN F; WALKER JP; PEYRIN L; SOULIER V; BADAN M; SCHULZ P
      REWARD DEPENDENCE IS POSITIVELY RELATED TO URINARY MONOAMINES IN NORMAL MEN

      Biological psychiatry
    44. KO HC; LU RB; SHIAH IS; HWANG CC
      PLASMA-FREE 3-METHOXY-4-HYDROXYPHENYLGLYCOL PREDICTS RESPONSE TO FLUOXETINE

      Biological psychiatry
    45. GESSA GL
      DYSTHYMIA AND DEPRESSIVE-DISORDERS - DOPAMINE HYPOTHESIS

      European psychiatry
    46. BREMNER JD; KRYSTAL JH; SOUTHWICK SM; CHARNEY DS
      NORADRENERGIC MECHANISMS IN STRESS AND ANXIETY .2. CLINICAL-STUDIES

      Synapse
    47. LITTLE PJ; PRICE RR; HINTON RK; KUHN CM
      ROLE OF NORADRENERGIC HYPERACTIVITY IN NEONATAL OPIATE ABSTINENCE

      Drug and alcohol dependence
    48. GARVEY MJ; TUASON VB
      DO LOW-LEVELS OF MHPG IN DEPRESSIVE SPECTRUM PATIENTS NORMALIZE AFTERSUCCESSFUL TREATMENT

      Neuropsychobiology
    49. ATOBE M; KUBOTA M; NAKAGAWARA M; KARIYA T
      EFFECT OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE INHIBITOR, CGS19281A, ON THE ALPHA-2-ADRENOCEPTOR FUNCTION IN THE HYPOTHALAMUS OF RATS IN COMPARISON WITH SKF29661, SKF64139 AND YOHIMBINE

      Neuropsychobiology
    50. DUNN AL; REIGLE TG; YOUNGSTEDT SD; ARMSTRONG RB; DISHMAN RK
      BRAIN NOREPINEPHRINE AND METABOLITES AFTER TREADMILL TRAINING AND WHEEL RUNNING IN RATS

      Medicine and science in sports and exercise
    51. GARVEY MJ; NOYES R; COOK B; BLUM N
      PRELIMINARY CONFIRMATION OF THE PROPOSED LINK BETWEEN REWARD-DEPENDENCE TRAITS AND NOREPINEPHRINE

      Psychiatry research
    52. FUKUDA M; HATA A; NIWA SI; HIRAMATSU KI; HONDA H; NAKAGOME K; IWANAMI A
      PLASMA VANILLYLMANDELIC ACID LEVEL AS AN INDEX OF PSYCHOLOGICAL STRESS-RESPONSE IN NORMAL SUBJECTS

      Psychiatry research
    53. GARVEY MJ; TUASON VB
      URINARY LEVELS OF 3-METHOXY-4-HYDROXYPHENYLGLYCOL PREDICT SYMPTOM SEVERITY IN SELECTED PATIENTS WITH UNIPOLAR DEPRESSION

      Psychiatry research
    54. HUGHES RN
      DRUGS WHICH INDUCE ANXIETY - CAFFEINE

      New Zealand journal of psychology
    55. HIRATA K; INAGAKI H; MINAMI M
      A NEW SOLID-PHASE EXTRACTION METHOD FOR H UMAN URINARY 3-METHOXY-4-HYDROXYPHENYLETHYLENEGLYCOL

      Yakugaku zasshi
    56. MARKIANOS M; SERETIS A; KOTSOU A; CHRISTOPOULOS M
      CSF NEUROTRANSMITTER METABOLITES IN COMATOSE HEAD-INJURY PATIENTS DURING CHANGES IN THEIR CLINICAL STATE

      Acta neurochirurgica
    57. SLAAP BR; VANVLIET IM; WESTENBERG HGM; DENBOER JA
      MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT

      Psychopharmacology
    58. DELEEUW AS; DENBOER JA; SLAAP BR; WESTENBERG HGM
      PENTAGASTRIN HAS PANIC INDUCING PROPERTIES IN OBSESSIVE-COMPULSIVE DISORDER

      Psychopharmacology
    59. BOURDEAUX R; CAPOLAGHI B; LACROIX C; YOUNOS C; LEHR PR
      ASSAY OF URINARY FREE AND CONJUGATED 3-METHOXY-4-HYDROXYPHENYLETHYLENEGLYCOL BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AMPEROMETRIC DETECTION

      Journal of chromatography B. Biomedical applications
    60. UESUGI H; TOYODA J; IIO M
      POSITRON EMISSION TOMOGRAPHY AND PLASMA BIOCHEMISTRY FINDINGS IN SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER ELECTROCONVULSIVE-THERAPY

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    61. BOER GJ; FEENSTRA MGP; BOTTERBLOM MJA; KORSE V; RIELE PT
      EARLY POSTNATAL APPEARANCE OF ENHANCED NORADRENALINE CONTENT IN THE BRAIN OF VASOPRESSIN-DEFICIENT BRATTLEBORO RAT - NORMAL ADRENOCEPTOR DENSITIES AND ABERRANT INFLUENCES OF VASOPRESSIN TREATMENT

      International journal of developmental neuroscience
    62. TAGHAVI E; MENKES DB; HOWARD RC; MASON PA; SHAW JP; SPEARS GFS
      PREMENSTRUAL-SYNDROME - A DOUBLE-BLIND CONTROLLED TRIAL OF DESIPRAMINE AND METHYLSCOPOLAMINE

      International clinical psychopharmacology
    63. WADA H; ITO H; ORIMO H; SATO A
      CENTRAL NORADRENERGIC SYSTEM OF AGED RATS IS ACTIVATED IN THE HALOTHANE-INDUCED HYPOTHERMIA

      Biogenic amines
    64. LAMBERT GW; KAYE DM; VAZ M; COX HS; TURNER AG; JENNINGS GL; ESLER MD
      REGIONAL ORIGINS OF 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN PLASMA - EFFECTS OF CHRONIC SYMPATHETIC NERVOUS ACTIVATION AND DENERVATION, AND ACUTE REFLEX SYMPATHETIC-STIMULATION

      Journal of the autonomic nervous system
    65. MOLLER SE; MAACHMOLLER B; OLESEN M; MADSEN B; MADSEN P; FJALLAND B
      TYROSINE METABOLISM IN USERS OF ORAL-CONTRACEPTIVES

      Life sciences
    66. KATOH A; EIGYO M; ISHIBASHI C; NAITOH Y; TAKEUCHI M; IBII N; IKEDA M; MATSUSHITA A
      BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC PROPERTIES OF DULOXETINE (LY248686), A REUPTAKE INHIBITOR OF NOREPINEPHRINE AND SEROTONIN, IN MICE AND RATS

      The Journal of pharmacology and experimental therapeutics
    67. LEVIN BE; BROWN KL; PAWAR G; DUNNMEYNELL A
      WIDESPREAD AND LATERALIZED EFFECTS OF ACUTE TRAUMATIC BRAIN INJURY ONNOREPINEPHRINE TURNOVER IN THE RAT-BRAIN

      Brain research
    68. MELLMAN TA; KUMAR A; KULICKBELL R; KUMAR M; NOLAN B
      NOCTURNAL DAYTIME URINE NORADRENERGIC MEASURES AND SLEEP IN COMBAT-RELATED PTSD

      Biological psychiatry
    69. LAWLOR BA; BIERER LM; RYAN TM; SCHMEIDLER J; KNOTT PJ; WILLIAMS LL; MOHS RC; DAVIS KL
      PLASMA 3-METHOXY-4-HYDROXYPHENYLGLYCOL (MHPG) AND CLINICAL SYMPTOMS IN ALZHEIMERS-DISEASE

      Biological psychiatry
    70. GODDARD AW; CHARNEY DS; GERMINE M; WOODS SW; HENINGER GR; KRYSTAL JH; GOODMAN WK; PRICE LH
      EFFECTS OF TRYPTOPHAN DEPLETION ON RESPONSES TO YOHIMBINE IN HEALTHY-HUMAN SUBJECTS

      Biological psychiatry
    71. TRESTMAN RL; YEHUDA R; COCCARO E; HORVATH T; KNOTT P; GABRIEL S; SIEVER LJ
      DIURNAL NEUROENDOCRINE AND AUTONOMIC FUNCTION IN ACUTE AND REMITTED DEPRESSED MALE-PATIENTS

      Biological psychiatry
    72. SANMARTINCLARK O; CUELLAR B; DEALBA J; LEZA JC; LORENZO P
      CHANGES INDUCED BY SODIUM CROMOGLYCATE IN BRAIN CATECHOLAMINE TURNOVER IN MORPHINE-DEPENDENT AND ABSTINENT MICE

      Psychopharmacology
    73. ERIKSSON E; ALLING C; ANDERSCH B; ANDERSSON K; BERGGREN U
      CEREBROSPINAL-FLUID LEVELS OF MONOAMINE METABOLITES - A PRELIMINARY-STUDY OF THEIR RELATION TO MENSTRUAL-CYCLE PHASE, SEX STEROIDS, AND PITUITARY-HORMONES IN HEALTHY WOMEN AND IN WOMEN WITH PREMENSTRUAL-SYNDROME

      Neuropsychopharmacology
    74. ROSE S; HINDMARSH JG; STEIGER MJ; BHATT M; QUINN NP; JENNER P; MARSDEN CD
      PLASMA HVA LEVELS FOLLOWING DEBRISOQUINE ADMINISTRATION DO NOT REFLECT CEREBRAL DOPAMINE LOSS IN EARLY PARKINSONS-DISEASE

      Clinical neuropharmacology
    75. GARVEY MJ; NOYES R; WOODMAN C; COOK B
      THE RELIABILITY OF URINARY 5-HIAA LEVELS

      Neuropsychobiology
    76. GARVEY MJ; HOLLON SD; TUASON VB
      RELATIONSHIP BETWEEN 3-METHOXY-4-HYDROXYPHENYLGLYCOL AND SUICIDE

      Neuropsychobiology
    77. SHEKIM WO; BYLUND DB; HODGES K; GLASER R; RAYPRENGER C; OETTING G
      PLATELET ALPHA(2)-ADRENERGIC RECEPTOR-BINDING AND THE EFFECTS OF D-AMPHETAMINE IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

      Neuropsychobiology
    78. BOWERS MB; MORTON JB
      REGIONAL BRAIN CATECHOLAMINES AND METABOLITES FOLLOWING THC, PCP AND MK-801

      Progress in neuro-psychopharmacology & biological psychiatry
    79. RAVINDRAN AV; BIALIK RJ; BROWN GM; LAPIERRE YD
      PRIMARY EARLY-ONSET DYSTHYMIA, BIOCHEMICAL CORRELATES OF THE THERAPEUTIC RESPONSE TO FLUOXETINE .2. URINARY METABOLITES OF SEROTONIN, NOREPINEPHRINE, EPINEPHRINE AND MELATONIN

      Journal of affective disorders
    80. FLECKENSTEIN AE; LOOKINGLAND KJ; MOORE KE
      ACTIVATION OF NORADRENERGIC NEURONS PROJECTING TO THE DIENCEPHALON FOLLOWING CENTRAL ADMINISTRATION OF HISTAMINE IS MEDIATED BY H-1 RECEPTORS

      Brain research
    81. MINDERAA RB; ANDERSON GM; VOLKMAR FR; AKKERHUIS GW; COHEN DJ
      NORADRENERGIC AND ADRENERGIC FUNCTIONING IN AUTISM

      Biological psychiatry
    82. PILETZ JE; DEMET E; GWIRTSMAN HE; HALARIS A
      DISRUPTION OF CIRCADIAN MHPG RHYTHMICITY IN MAJOR DEPRESSION

      Biological psychiatry
    83. MCCANN UD; PENETAR DM; SHAHAM Y; THORNE DR; SING HC; THOMAS ML; GILLIN JC; BELENKY G
      EFFECTS OF CATECHOLAMINE DEPLETION ON ALERTNESS AND MOOD IN RESTED AND SLEEP-DEPRIVED NORMAL VOLUNTEERS

      Neuropsychopharmacology
    84. SCHMAUSS M; ERFURTH A
      PREDICTION OF ANTIDEPRESSANT RESPONSE - C RITICAL-REVIEW AND PERSPECTIVES

      Fortschritte der Neurologie, Psychiatrie
    85. WHITE HL; ASCHER JA
      PRECLINICAL AND EARLY CLINICAL-STUDIES WITH BW-1370U87, A REVERSIBLE COMPETITIVE MONOAMINE OXIDASE-A INHIBITOR

      Clinical neuropharmacology
    86. HEDEEN KM; WHITE HL; COOPER BR; CONNER GW; NORTON RM
      EFFECT OF A NOVEL MONOAMINE OXIDASE-A INHIBITOR, BW 1370U87, ON URINARY 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN NORMAL VOLUNTEERS

      Drug development research
    87. NOGUCHI T; SHIMODA K; TAKAHASHI S
      CLINICAL-SIGNIFICANCE OF PLASMA-LEVELS OF CLOMIPRAMINE, ITS HYDROXYLATED AND DESMETHYLATED METABOLITES - PREDICTION OF CLINICAL OUTCOME IN MOOD DISORDERS USING DISCRIMINANT-ANALYSIS OF THERAPEUTIC DRUG-MONITORING DATA

      Journal of affective disorders
    88. KAREGE F; BOVIER P; HILLERET H; GAILLARD JM
      LACK OF EFFECT OF ANXIETY ON TOTAL PLASMA MHPG IN DEPRESSED-PATIENTS

      Journal of affective disorders
    89. EMOTO H; TANAKA M; KOGA C; YOKOO H; TSUDA A; YOSHIDA M
      CORTICOTROPIN-RELEASING FACTOR ACTIVATES THE NORADRENERGIC NEURON SYSTEM IN THE RAT-BRAIN

      Pharmacology, biochemistry and behavior
    90. HALPERIN JM; NEWCORN JH; SCHWARTZ ST; MCKAY KE; BEDI G; SHARMA V
      PLASMA-CATECHOLAMINE METABOLITE LEVELS IN ADHD BOYS WITH AND WITHOUT READING DISABILITIES

      Journal of clinical child psychology
    91. FUJITA K; IIJIMA N; SUZUKI S; NAKAZAWA K
      EFFECTS OF CLONIDINE ON DESIPRAMINE-INDUCED AND DESMETHYLCLOMIPRAMINE-INDUCED 3-METHOXY-4-HYDROXYPHENYLGLYCOL LEVELS IN RAT-BRAIN

      European journal of pharmacology
    92. GABEL S; STADLER J; BJORN J; SHINDLEDECKER R; BOWDEN CL
      BIODEVELOPMENTAL ASPECTS OF CONDUCT DISORDER IN BOYS

      Child psychiatry and human development
    93. EMOTO H; KOGA C; ISHII H; YOKOO H; YOSHIDA M; TANAKA M
      A CRF ANTAGONIST ATTENUATES STRESS-INDUCED INCREASES IN NA TURNOVER IN EXTENDED BRAIN-REGIONS IN RATS

      Brain research
    94. MINE K; OKADA M; MISHIMA N; FUJIWARA M; NAKAGAWA T
      PLASMA-FREE AND SULFOCONJUGATED MHPG IN MAJOR DEPRESSIVE-DISORDERS - DIFFERENCES BETWEEN RESPONDERS TO TREATMENT AND NONRESPONDERS

      Biological psychiatry
    95. GUTHRIE SK; GRUNHAUS L; PANDE AC; HARIHARAN M
      NORADRENERGIC RESPONSE TO INTRAVENOUS YOHIMBINE IN PATIENTS WITH DEPRESSION AND COMORBIDITY OF DEPRESSION AND PANIC

      Biological psychiatry
    96. GARVEY MJ; HOLLON SD; DERUBEIS RJ
      CHANGES IN URINARY MHPG DURING TREATMENT OF DEPRESSION WITH IMIPRAMINE

      Biological psychiatry
    97. BOWERS MB
      PSYCHOTIC-PATIENTS WITH INCREASED PLASMA HVA AND MHPG OR INCREASED HVA ALONE

      Biological psychiatry
    98. MULLER HU; RIEMANN D; BERGER M; MULLER WE
      THE INFLUENCE OF TOTAL SLEEP-DEPRIVATION ON URINARY-EXCRETION OF CATECHOLAMINE METABOLITES IN MAJOR DEPRESSION

      Acta psychiatrica Scandinavica
    99. ALEVIZOS B; HATZIMANOLIS J; MARKIANOS M; STEFANIS CN
      CLINICAL, ENDOCRINE AND NEUROCHEMICAL EFFECTS OF MOCLOBEMIDE IN DEPRESSED-PATIENTS

      Acta psychiatrica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 22:47:41